News Releases

February 22, 2021
Cogent Biosciences Appoints Accomplished Finance Executive Todd E. Shegog to its Board of Directors
CAMBRIDGE, Mass. , Feb. 22, 2021 /PRNewswire/ --  Cogent Biosciences, Inc.  (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the appointment of Todd E. Shegog to its Board of Directors.
February 18, 2021
Cogent Biosciences to Present at Virtual 10th Annual SVB Leerlink Global Healthcare Conference 2021
CAMBRIDGE, Mass. , Feb. 18, 2021 /PRNewswire/ --  Cogent Biosciences, Inc.  (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that Andrew Robbins , Chief Executive Officer and President, will present at the 10 th
February 11, 2021
Cogent Biosciences to Present at LifeSci Partners Virtual Precision Oncology Day 2021
CAMBRIDGE, Mass. , Feb. 11, 2021 /PRNewswire/ -- Cogent Biosciences , Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that Andrew Robbins , Chief Executive Officer and President, will present a corporate
Displaying 11 - 13 of 13
The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Unum disavows any obligation to update the information contained in such press releases after the date of their issuance.